Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia?
Mazza
Alberto
A
Cuppini
Stefano
S
Zamboni
Sergio
S
Schiavon
Laura
L
Zattoni
Luca
L
Viale
Andrea
A
Corbetti
Francesco
F
Ravenni
Roberta
R
Sacco
Alberto
A
Casiglia
Edoardo
E
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D015415:Biomarkers; D016893:Carotid Stenosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D005352:Fibromuscular Dysplasia / Q000150:complications* / Q000000981:diagnostic imaging; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007093:Imidazoles / Q000627:therapeutic use*; D007249:Inflammation / Q000378:metabolism; D008875:Middle Aged; D017382:Reactive Oxygen Species / Q000378:metabolism; D013777:Tetrazoles / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D047228:Angiotensin II Type 1 Receptor Blockers; D015415:Biomarkers; D007093:Imidazoles; D017382:Reactive Oxygen Species; D013777:Tetrazoles; C437965:olmesartan